QRxPharma, Genetic Technologies and Crusader Resources featured in capital raising news on Friday.
■ QRxPharma raised $25 million in a placement to Australian, US and UK-based fund managers. The company also launched a one-for-20 non-renounceable rights issue to raise another $10.4 million. RBS Morgans and Bell Potter led the deal.
Loading...
Anthony Macdonald is a Chanticleer columnist. He is a former Street Talk co-editor and has 10 years' experience as a business journalist and worked at PwC, auditing and advising financial services companies. Connect with Anthony on Twitter. Email Anthony at a.macdonald@afr.com
